Protecting infants against respiratory syncytial virus this winter — ECDC issues advice
As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of…
A new tool to find hidden ‘zombie cells’
When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells — also known as “zombie cells” — stop dividing but don’t die…
11 million lives lost each year: urgent action needed on neurological care
The World Health Organization (WHO) today warns that less than one in three countries around the world has a national policy to address the growing burden of neurological disorders, responsible…
FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
harmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq®) as a maintenance treatment for adults with…
Simple test can predict risk of severe liver disease
A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can predict the risk of developing severe liver disease. The method…
Repeated head impacts cause early neuron loss and inflammation in young athletes
Research supported by the National Institutes of Health (NIH) shows that repeated head impacts from contact sports can cause early and lasting changes in the brains of young- to middle-aged…
Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer’s disease, using a single,…
Study reveals new genetic mechanism behind autism development
Scientists from The Hospital for Sick Children (SickKids) and University of Las Vegas Nevada (UNLV) have uncovered a genetic link between autism spectrum disorder (ASD) and a rare genetic condition…
Global data show real-world effectiveness of romosozumab for patients at high fracture risk
UCB, a global biopharmaceutical company, today announced findings from a collection of real-world evidence studies to reaffirm the effectiveness and clinical impact of romosozumab, the only dual-acting osteoporosis treatment that…
Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes. New England Journal of Medicine #ACC25
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.…